Hematology TimesApplying ECHELON-2 results to clinical practiceJanuary 31, 2019Aggressive LymphomasLymphoma & Plasma Cell DisordersT Cell Lymphomas
Hematology NewsIPH4102 on fast track for Sézary syndromeJanuary 30, 2019T Cell LymphomasLymphoma & Plasma Cell DisordersNonmelanoma Skin Cancer
Hematology NewsUmbralisib gains FDA breakthrough designation for MZLJanuary 25, 2019Indolent LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsNovel bispecific CAR shows promise in B-cell malignanciesJanuary 25, 2019Aggressive LymphomasCellular TherapyLymphoma & Plasma Cell DisordersTransplantationImmuno-oncologyImmunotherapyB Cell Lymphoma
Hematology NewsImaging, radiotherapy clarified in new PMBCL guidelinesJanuary 25, 2019Aggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology TimesCombo treatment may improve quality of life in CTCLJanuary 24, 2019T Cell LymphomasLymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology TimesAre single agents better than chemo for relapsed/refractory PTCL?January 24, 2019Lymphoma & Plasma Cell DisordersAggressive LymphomasT Cell Lymphomas
Hematology NewsWith RRMM and renal impairment, carfilzomib improves survivalJanuary 22, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsZanubrutinib receives breakthrough designation for MCLJanuary 18, 2019Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology TimesChidamide may be more effective in PTCL than previously thoughtJanuary 16, 2019T Cell LymphomasAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsArmored CAR protects T cells, induces remissionsJanuary 4, 2019Cellular TherapyImmuno-oncologyLymphoma & Plasma Cell DisordersCLLAggressive LymphomasImmunotherapyB Cell Lymphoma
Hematology TimesCMT provides survival benefit in young HL patientsJanuary 4, 2019Lymphoma & Plasma Cell DisordersPediatricsHodgkin Lymphoma
Hematology TimesGroup proposes new grading systems for CRS, neurotoxicityJanuary 3, 2019Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsLenalidomide maintenance improves MCL survival after ASCTJanuary 2, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology TimesRisk of second cancers in Hodgkin lymphoma survivorsDecember 27, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
